News & updates

LUMC and Ixaka announce collaboration to advance cell therapy development

Created on:

March 30, 2021

The Leiden University Medical Center (LUMC) and Ixaka Ltd. have announced a research collaboration on 30 March 2021, to better understand REX-001, Ixaka’s lead cell therapy product. The project will be led by Professor Paul Quax, Head of Experimental Vascular Surgery at the LUMC, to support accelerated development of REX-001 in Phase III clinical trials for the treatment of chronic limb-threatening ischemia (CLTI).

CLTI is a life-threatening vascular disease caused by a build-up of fatty deposits in the arteries, which limits the adequate flow of blood and oxygen to a specific part of the body, such as the leg muscles. According to Quax: “there are not many available options to treat the disease as it progresses and the current procedures to manage symptoms of CLTI at advanced stages are often unsuitable or ineffective”. For example, cutting-edge methods such as the use of minimally-invasive catheters and surgical reconstruction do not help in restoring blood flow or preventing major amputations. “This has created a critical need for new and innovative therapies”, highlights Quax.

Read the full article

More news & updates

A Marie Skłodowska-Curie – Postdoctoral Fellowship in Leiden: success story by Prasanna Iyengar

June 21, 2021

In 2018, Prasanna Iyengar was awarded a Marie Skłodowska-Curie – Postdoctoral Fellowship (MSCA-IF) to implement a research project on bladder cancer at Leiden University Medical Center (LUMC) in The Netherlands. This two-year fellowship allowed Prasanna to pursue an independent line of research as a senior postdoc, thereby elucidating mechanisms of bladder cancer metastasis as well as further developing his career track.

An insight into the value of international collaborations in global health(care) challenges, to be further highlighted during Leiden2022

May 25, 2022

Leiden2022 marks what the City of Leiden has achieved in science till date and how it wishes to move forward to contribute to challenges of various kinds. The LUMC is one of many organizations showcasing science in practice with interactive events for a variety of target groups. Like with all Leiden based companies, Leiden2022 offers the LUMC the opportunity to show its societal and academic value on an international stage, strengthening its international position, as well as explore possibilities for new international collaborations to contribute to global healthcare challenges even more comprehensively. The Global Impact in Health symposium on May 30^th, 2022, part of the LSH week, aims to stimulate just that by bringing together healthcare experts from all over the world working on a broad range of important health(care) related research and projects. Here’s a few things you can expect.

LUMC Global is looking for a PhD Candidate/Physician-researcher Obstetrics

September 23, 2021

LUMC Global has set out to stimulate international connections in (bio)medical research and education to contribute to global healthcare. Setting up several PhD projects has been one of the key elements in doing this and we’re very proud we’ve been able to set up as many as eight different PhD projects. We are now looking for a Global PhD candidate in Obstetrics in a collaborative projects with Karolinska Institutet, Sweden and UZ Leuven, Belgium.